AVO.L Share News (AVO)
AVO Share
AVO Share
AVO Share
AVO Share
AVO
AVO Share
AVO Broker
AVO Directors
AVO Financial
AVO
AVO Short
AVOThu, 17th Dec 2015 10:08
LONDON (Alliance News) - Advanced Oncotherapy PLC Thursday said Non-Executive Director Michael Bradfield bought 750,000 shares at a price of 5.5 pence per share Wednesday.
Following this transaction, Bradfield now holds 122.8 million shares, which represents 8.66% of the issued share capital.
Shares in the medical technology company were up 4.2% at 5.60p Thursday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
DIRECTOR DEALINGS: Advanced Oncotherapy Exec Chair Ups Stake To 2.7%
Read moreAdvanced Oncotherapy Annual Loss Flat; Gets LIGHT System Funding
Read moreIN BRIEF: Advanced Oncotherapy Reduces Board Members To 8 From 12
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost
Read more
(Sharecast News) - Proton therapy developer Advanced Oncotherapy has reached agreement with University Hospitals Birmingham NHS Foundation Trust (UHB), the acute service provider delivering general hospital services for Birmingham and specialist treatments for the West Midlands and nationally, to install a 'LIGHT' system, it announced on Thursday.
Read moreAdvanced Oncotherapy To Install LIGHT System At Birmingham Hospital
Read more(Sharecast News) - Proton therapy systems developer Advanced Oncotherapy announced on Monday that the Mediterranean Hospital of Limassol in Cyprus has agreed to purchase a 'LIGHT' system for €50m.
Read moreAdvanced Oncotherapy Sells Proton Therapy System To Cypriot Hospital
Read more(Sharecast News) - Proton therapy cancer treatment company Advanced Oncotherapy announced a memorandum of understanding with The London Clinic on Tuesday, to operate its first commercial 'LIGHT' facility on Harley Street in London.
Read moreAdvanced Oncotherapy Teams With London Clinic To Deliver New Therapy
Read moreAdvanced Oncotherapy Launches Two-Year Collaborative Research Study
Read moreAdvanced Oncotherapy Launches Subscription To Fund LIGHT Approval
Read moreAdvanced Oncotherapy Interim Loss Widens But LIGHT System Progresses
Read more(Alliance News) - Cancer therapy developer Advanced Oncotherapy PLC said on Monday that it has raised GBP3,600 through a warrants issue.It issued 2,400 shares at a price of 150.00 pence and
Read more